New vistas in opioid control of pain

Curr Opin Pharmacol. 2012 Feb;12(1):87-91. doi: 10.1016/j.coph.2011.10.020. Epub 2011 Nov 19.

Abstract

The μ-opioid receptors mainly contribute to the control of pain transmission, while a number of splice variants may have different physiological roles. In fact, some μ-opioid receptor agonists show distinct antinociceptive properties probably mediated via splice variants insensitive to traditional μ-opioid receptor agonists. These atypical μ-opioid receptor agonists are extremely effective against morphine-resistant interactive pain and lack the psychological dependence liability. μ-Opioid receptor splice variants specific for these atypical agonists may be the target for better analgesics effective against morphine-resistant interactive pain and lacking psychological dependence liability.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Analgesics, Opioid / pharmacology*
  • Analgesics, Opioid / therapeutic use*
  • Gene Expression Regulation
  • Genetic Variation
  • Humans
  • Pain / drug therapy*
  • Receptors, Opioid / genetics
  • Receptors, Opioid / metabolism*

Substances

  • Analgesics, Opioid
  • Receptors, Opioid